NewAmsterdam Pharma Co NV (FRA:KH6) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Days Payable?

NewAmsterdam Pharma Co NV's average Accounts Payable for the six months ended in Dec. 2023 was €18.22 Mil. NewAmsterdam Pharma Co NV's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for NewAmsterdam Pharma Co NV's Days Payable or its related term are showing as below:

FRA:KH6's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 147.29
* Ranked among companies with meaningful Days Payable only.

NewAmsterdam Pharma Co NV's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

NewAmsterdam Pharma Co NV Days Payable Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Days Payable Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of NewAmsterdam Pharma Co NV's Days Payable

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's Days Payable distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's Days Payable falls into.

NewAmsterdam Pharma Co NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

NewAmsterdam Pharma Co NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (11.189	+	15.518)	/	2 )	/	0	*	365
=	13.3535					/	0	*	365
=	N/A

NewAmsterdam Pharma Co NV's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (20.918	+	15.518)	/	2 )	/	0	*	365 / 2
=	18.218					/	0	*	365 / 2
=	N/A

NewAmsterdam Pharma Co NV Days Payable Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NAMS:USA KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines